info		Neumünster Abbey, Luxemburgo
		01.03.2015|04.03.2015
		www.eacr.org

The EACR-OECI Conference on Precision Medicine for Cancer will be held from 1 – 4 March 2015 at Neumünster Abbey, Luxembourg.

Recent advances in technology have provided an unprecedented opportunity to develop platforms for implementing precision/personalised medicine in cancer. This conference will discuss the challenges that face us in implementing these approaches.

Although our understanding of the pathogenesis of cancer has advanced enormously in recent years, we have only just begun to successfully translate this into improvements in the clinical management of patients. A significant opportunity is offered by the knowledge that cancer cells are ‘addicted’ to certain altered genes, a vulnerability that can be exploited therapeutically. A number of cancer-causing genes have been identified that are recurrently altered and stimulate tumour growth. These ‘driver genes’ correspond to oncogenes (or tumour suppressor genes) that are mutated or deregulated (e.g., amplified), causing the tumour to become dependent on the lesion(s) for survival and/or proliferation.